Page last updated: 2024-08-26

gamma-tocopherol and cyclin d1

gamma-tocopherol has been researched along with cyclin d1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azzi, A; Gysin, R; Visarius, T1
Azzi, A; Betti, M; Conte, C; Floridi, A; Galli, F; Pistilli, A; Rende, M; Stabile, AM1
Chen, YK; Guan, F; Lee, MJ; Li, G; Lin, Y; Liu, AB; Shih, W; Yang, CS; Yang, Z1
Abbruzzese, A; Beninati, S; Caraglia, M; Torricelli, P1
Bazzaz, R; Bijanpour, H; Pirouzpanah, SMB; Rashtchizadeh, N; Yaghmaei, P1

Other Studies

5 other study(ies) available for gamma-tocopherol and cyclin d1

ArticleYear
Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:14

    Topics: alpha-Tocopherol; Antineoplastic Agents; Caco-2 Cells; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; DNA, Neoplasm; Down-Regulation; gamma-Tocopherol; Humans; Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002
The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
    Archives of biochemistry and biophysics, 2004, Mar-01, Volume: 423, Issue:1

    Topics: alpha-Tocopherol; Antioxidants; Cell Division; Chromans; Cyclin D1; Dose-Response Relationship, Drug; gamma-Tocopherol; Humans; Male; Propionates; Prostatic Neoplasms

2004
δ- and γ-tocopherols, but not α-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:4

    Topics: Aldehydes; alpha-Tocopherol; Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Cyclin D1; Dinoprost; Dinoprostone; gamma-Tocopherol; Immunohistochemistry; Male; Models, Chemical; Rats; Rats, Inbred F344; Tocopherols; Tyrosine

2012
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins.
    Amino acids, 2013, Volume: 44, Issue:1

    Topics: alpha-Tocopherol; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin E; DNA Replication; Down-Regulation; Enzyme Induction; gamma-Tocopherol; GTP-Binding Proteins; Humans; Male; Prostatic Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Transglutaminases; Up-Regulation; Vitamins

2013
Adjuvant therapy with γ-tocopherol-induce apoptosis in HT-29 colon cancer via cyclin-dependent cell cycle arrest mechanism.
    Journal of biochemical and molecular toxicology, 2019, Volume: 33, Issue:11

    Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle Checkpoints; Cell Proliferation; Chemotherapy, Adjuvant; Colonic Neoplasms; Cyclin D1; Cyclin E; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Enzyme Activators; Fluorouracil; gamma-Tocopherol; Gene Expression; HT29 Cells; Humans; Proto-Oncogene Proteins c-bcl-2

2019